Yüklüyor......
Short Communication: The Effect of Rosuvastatin on Vascular Disease Differs by Smoking Status in Treated HIV Infection
Smoking is an important contributor to cardiovascular disease risk and is highly prevalent in the HIV population. In the Stopping Atherosclerosis and Treating Unhealthy Bone with Rosuvastatin in HIV trial (SATURN-HIV), a 96-week, randomized placebo-controlled study testing the effect of rosuvastatin...
Kaydedildi:
| Yayımlandı: | AIDS Res Hum Retroviruses |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Mary Ann Liebert, Inc.
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5863076/ https://ncbi.nlm.nih.gov/pubmed/28974102 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2017.0164 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|